Gutzeit, Julian http://orcid.org/0000-0002-1434-1645
Weiß, M.
Nürnberger, C.
Lemhöfer, C.
Appel, K. S.
Pracht, E.
Reese, J.-P.
Lehmann, C.
Polidori, M. C.
Hein, G.
Deckert, J.
Funding for this research was provided by:
Universitätsklinikum Würzburg
Article History
Received: 22 March 2024
Accepted: 15 July 2024
First Online: 25 July 2024
Declarations
:
: JG receives funding from the Nationales Pandemie Kohorten Netz - Therapeutische Interventionsplattform (NAPKON-TIP) network, which is funded by the Federal Ministry of Education and Research. R.P. is supported by grants in the projects COMPASS and NAPKON. The COMPASS and NAPKON projects are part of the German COVID-19 Research Network of University Medicine (“Netzwerk Universitätsmedizin”), funded by the German Federal Ministry of Education and Research (funding reference 01KX2021). MW has nothing to disclose. CN has nothing to disclose. CL (University Hospital Jena) received institutional funding from Federal Joint Committee (G-BA) within the Innovationfond (WATCH, Grant numbers L01NVF22114), Editorial Board Member of ‘Physikalische Medizin, Rehabilitationsmedizin, Kurortmedizin’, Network University Medicine (NUM)/ German Federal Ministry of Education and Research (BMBF) - Speaker Physical and Rehabilitation Group (unpaid), board member of German Society of Physical and Rehabilitation Medicine (Deutsche Gesellschaft für Physikalische und Rehabilitative Medizin e.V. (DGPRM), unpaid). KA has nothing to disclose. EP has nothing to disclose. JPR reports grants from the German Ministry of Research and Education within NUM, CAEHR, RECAP; grants from Bavarian State (ministry for science and the arts, DigiOnko), grants from Federal Joint Committee (G-BA) within the Innovationfond (Peri-OP, StarkeR), grants from the German Center for Lung Research within PASSION, personal fees and fees for EBM Training Lecture from the Landesaerztekammer Hessen. CL (University of Cologne) has nothing to disclose. MPN has nothing to disclose. GH has nothing to disclose; JD is an investigator in the EU-Horizon-funded Predict Study of P1Vital and Co-Applicant with BioVariance in the InDepth Study funded by the Bavarian State Government. All other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript, except for the Network University Medicine.